Navigation Links
Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
Date:1/29/2008

>Summary:

Net loss: $ (16,769) $4 $(37) $ (1,025) $(17,827)

Net loss per share -

basic and diluted: $(18.60) $ 0.01 $(0.04) $(1.14) $(19.77)

Weighted average

number of shares

outstanding: 901,748 901,748

Table 4

Amicus Therapeutics, Inc.

Reconciliation of GAAP to non-GAAP Measures for the

Statement of Operations Information for Year Ended December 31, 2007

(Unaudited)

(In thousands, except share and per share amounts)

Change

in Fair

Value

of Preferred

Warrant Stock Stock GAAP as

Non-GAAP Liability Accretion Compensation Reported

Income Statement

Classifications:

Revenue $1,784 $1,784

Research and

development (29,480) $- $- $(1,594) (31,074)

General and

administrative (12,887) (2,391) (15,278)

Depreciation and

amortization (1,237) (1,237)

Interest income 5,135 5,135

Interest expense (348) (348)

Change in fair value of

warrant liability - (149) (149)

Preferred stock accretion - (351) (351)

Summary:

Net loss: $(37,033) $(149) $(351) $(3,985) $(41,518)

Net loss per share -

basic and diluted: $(2.80) $(0.01) $(0.03) $(0.30) $(3.14)
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
2. Amicus Therapeutics to Host R&D Day
3. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
4. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
5. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
6. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
7. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
9. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
10. Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
11. Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... - SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a ... commercializes proprietary technologies and products for advanced microarray ... approval from the TSX Venture Exchange to extend ... warrants ("the Warrants") of the Company, which were ... private placement financing. Each Warrant entitles ...
(Date:4/17/2015)... , April 17, 2015  US-Australian drug discovery company, ... Memorandum of Understanding with the Feinstein Institute for ... York to collaborate with the objective ... The collaboration brings together the drug discovery ... expertise of the Feinstein Institute in neurosciences and ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 LC ... proteomics technologies, announced today that it is seeking ... an innovative multiplex PCR based targeted sequencing technology. ... sequence analysis, that enables accurate detection of rare ... and Omega-Primerâ„¢ technologies. The company will collaborate with ...
(Date:4/16/2015)... Carolina (PRWEB) April 17, 2015 ... steam system services, released their newly designed, state-of-the-art ... The customer facing website effectively promotes the Spirax ... , All the information that a site visitor ... system services, company capabilities, industries serviced, the latest ...
Breaking Biology Technology:SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Spirax Sarco website has a new look 2
... Entrepreneurial Excellence in Emerging Category, LOS ANGELES, ... announced that Dr. Donald Rice, Founder, President, & ... Year(R) 2008 Award in the,Emerging category in the ... LLP, the award recognizes outstanding entrepreneurs who are ...
... Pathway Would Also Lower Total,Expenditures for Biologics by $25 ... The Congressional Budget,Office (CBO) today released a cost analysis ... biologics -- or biogenerics -- would save,the federal government ... biologics by $25 billion over the same time period., ...
... advanced formula,scar gel is a unique patented silicone ... standard for scar treatment and abnormal scar,prevention. The ... is ONLY available from Advanced Bio-Technologies, Inc.(ABT)., ... label. Doctors,and customers should not be misled by ...
Cached Biology Technology:Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area 2Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area 3CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years 2
(Date:3/24/2015)... 24, 2015 Research and Markets ( ... "Global Iris Recognition Market 2015-2019" report to their ... Recognition market to grow at a CAGR of 23.5 ... covers the present scenario and the growth prospects of ... To calculate the market size, the report considers the ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ™, ... today announced that its U.are.U ® 4500 ... Goorin Bros . to achieve PCI compliance ... secures access to the POS terminal, protecting the ... of data breaches. With one-third ...
(Date:3/23/2015)... 2015  In the 2014 fiscal year, irs.gov recorded ... This figure accounts for a fraction of the estimated ... Report, exceeds $11 billion globally. The polygraph has traditionally ... has occurred. Investor Mark Saint Juste along ... Paolella partnered to administer the test in a ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... Dr Veerle Huvenne of the United Kingdom,s National Oceanography Centre ... million Euros over five years to map complex habitats in ... The European Research Council (ERC) ,Starting Grant, scheme aims to ... own research groups. The grants are highly competitive, and this ...
... October 27, 2010 TEL AVIV, Israel Assembled ... Israel under the EUREKA Chairmanship year, EUREKA,s High Level ... of promising cooperative R&D projects in a variety of ... accordance with EUREKA,s strategic targets defined for the 2010-2011 ...
... Human Reproduction and Embryology (ESHRE) has published the first textbook ... English language. A Dutch textbook, in layout and ... higher professional education (Master,s level), was the basis for this ... nurses working in reproductive health. For a net ...
Cached Biology News:European R&D leaders assembled in Tel Aviv will invest $70 million in joint R&D initiatives 2
... dotLab System brings together two mature, ... immobilized capture surfaces. This combination produces ... for the detection of molecular binding ... labels. , Protein-specific capture molecules are ...
... 5'G AATTC3' 3'CTTAA G5' Inactivation Conditions: Heat inactivation ... Storage Conditions: 10mM Tris-HCl (pH 7.5), 100mM KCl, ... BSA, 50% glycerol. Shipping and Storage: Shipped on ... unit is defined as the amount of enzyme ...
The HEPTEST assays provide a sensitive, simple, rapid, and convenient in vitro quantitation of heparin, low molecular weight heparins, and heparinoids in plasma and whole blood. Sample Type: wh...
... a comprehensive experiment based analysis package designed ... yet sophisticated and powerful functionality., Image acquisition ... cameras for easy image capture. Sequential ... Video Playback Saturation Warning ...
Biology Products: